XML 16 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities    
Net increase (decrease) in net assets resulting from operations $ 511,464 $ 7,066,223
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Origination and purchase of investments (28,376,358) (40,290,669)
Payment in-kind interest and dividends (1,472,740) (3,965,589)
Sales and repayments of investments 25,092,011 64,430,793
Net realized (gain) loss on investments (581,343) 12,157,003
Net change in unrealized appreciation/depreciation on investments 1,786,018 (13,509,819)
Amortization of discount/premium on investments (965,678) (1,582,325)
Amortization of deferred debt issuance costs 461,471 470,271
Amortization of original issue discount- 2026 Notes 53,333 53,333
Net (increase) decrease in operating assets:    
Interest receivable (141,839) (218,101)
Payment-in-kind interest receivable (103,513) 68,638
Principal receivable 424,051 (20,602)
Due from affiliate 0 515,361
Long-term receivable 489,365 (644,831)
Escrow receivable 0 (99,198)
Short-term receivable (191,407) 0
Prepaid expenses and other assets (214,304) (121,775)
Net increase (decrease) in operating liabilities:    
Payable for investments purchased 1,660,636 (311,970)
Interest payable 940,866 381,385
Deferred income liability 517,499 0
Directors fees payable (81,323) (4,343)
Accrued expenses and other liabilities (29,446) 612,334
Base management fees payable 6,049 (101,114)
Income-based incentive fees payable (137,550) 501,539
Net cash (used in) provided by operating activities (352,738) 25,386,544
Cash Flows from Financing Activities:    
Payment for deferred financing costs 0 (1,010,788)
Issuance of common shares 0 0
Distributions to stockholders (5,118,649) (6,449,605)
Proceeds from borrowing on revolving financing facility 18,500,000 13,500,000
Repayments of borrowing on revolving financing facility (13,500,000) (36,000,000)
Net cash (used in) provided by financing activities (118,649) (29,960,393)
Net change in cash (471,387) (4,573,849)
Cash and restricted cash at beginning of year 12,104,547 14,664,362
Cash and restricted cash at end of period 11,633,160 10,090,513
Supplemental and non-cash financing cash flow information:    
Cash paid for interest 4,777,130 5,607,216
Cash paid for taxes 469,862 265,000
Issuance of shares pursuant to Dividend Reinvestment Plan 70,453 29,311
Non-cash purchase of investments (11,306,892) (18,213,917)
Non-cash sale of investments 11,306,892 18,213,917
Cash 3,860,953 1,748,802
Cash, restricted 7,772,207 8,341,711
Cash and restricted cash $ 11,633,160 $ 10,090,513